Back to Trades
Puylaert Kevin
Chief Sales OfficerCIK 0002119354
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2026
Across 7 filings between 2026, Puylaert Kevin, Chief Sales Officer, has disclosed $834.2K in transactions — all concentrated in SOPHiA GENETICS SA (SOPH). Their disclosed trades are heavily weighted toward selling — $0 in buys and $4.3K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 7 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Sell | $1.1K |
| Apr 21 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Sell | $168 |
| Apr 8 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Sell | $3.0K |
| Apr 8 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Grant | $415.0K |
| Apr 3 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Grant | $415.0K |
| Apr 1 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Sell | $14 |
| Mar 18 | SOPH SOPHiA GENETICS SA | Puylaert Kevin | Chief Sales Officer | Other | $0 |
7 filings